According to the research highlights of the July 2008 issue on Opthalmology, the Ophthalmologists of America are continuing to develop treatments for Glucoma. The July 
ssue contains a large study of outcomes of incisional surgeries, used to reduce the pressure inside the eye of the Medicare patients.
Glucoma is a disease by which maximum number of people throughout the world gets blind. This happens due to the damage of the disc of the eye's optic nerve, which compromise the transmission of images to the brain and thus leads to blindness if not treated properly.
The records of 14,491 Medicare beneficiaries were diagnosed with glaucoma who received one of three incisional surgeries — primary trabeculectomy (PT), trabeculectomy in presence of scarring from previous ocular surgery or trauma (TS), or implantation of a glaucoma drainage device (GDD) — between 1994 and 2003 by Frank A. Sloan, PhD, and colleagues.
All the three surgeries are designed to improve the drainage of fluid from the eye to reduce IOP. In trabeculectomy (both PT and TS), a small portion of the trabecular meshwork is removed to increase fluid flow, and in GDD a tiny implanted shunt is used to bypass the trabecular meshwork and redirect fluid flow. These incisional techniques have benefited millions of glaucoma patients who otherwise might be blind or have very low vision.
The study found that, although adverse outcomes were uncommon for all three surgeries, rates of severe outcomes, less severe outcomes, and progression to low vision or blindness were higher for persons who received GDD than for those who received PT or TS.
Concluding that with continued treatment, doctors can give hope to their patients having end-stage Glucoma, as said by the M.D Dr. Jason W. Much who lead the study.
Source: Business Wire
Filed under Eye Diseases, Eye Surgery, Eye Treatment, Glaucoma, Improved Vision, Macular Degeneration | Tags: eye, Glaucoma, Glaucoma Drainage Damage, Ocular Surgery, Opthalmology, primary trabeculectomy, trabeculectomy in presence of scarring from previous oc | Comment Below
Related?
Implantable miniature telescope for End-Stage AMD received FDA approvalMarch 31st, 2009 Good news for patients with untreatable end-stage age-related macular degeneration. Developer of advanced visual prosthetic devices for individuals with age-related macular degeneration, VisionCare Ophthalmic Technologies, Inc., announced today about the FDA approval of their Implantable telescope for End-Stage AMD.
Blood pressure drug Candesartan retain hope for diabetic ratinopathyJanuary 7th, 2009 New clinical trials bring hope for diabetes patents facing diabetic retinopathy, a disease which has the potential of causing blindness. Diabetic retinopathy is a hidden danger for diabetic patients, Small blood vessels throughout the entire body are destroyed due to type 1 diabetes.
Hope for Age Related Macular Degeneration with LucentisDecember 31st, 2005 Genentech Inc. has applied for U.S.
Kuwaiti doctor offers cataract surgery without retina transplantOctober 22nd, 2008 A Kuwaiti eye specialist has something to offer to the cataract patients. Khaled Al-Sabti, head of the retina ward in the Al-Bahar Eye Centre claimed to have invented a technique to treat cataract with a rentiscope.
What is Advance or End stage Macular Degeneration?April 3rd, 2009 Macular degeneration is a disorder of the central retina, or macula, which is responsible for detailed vision that controls important functional visual activities like recognizing faces and watching television. According to the National Eye Institute over 1.7 million Americans over age 50 suffer mild to profound vision loss from advanced AMD, which frequently culminates as End-Stage AMD (visual impairment due to untreatable advanced AMD).
Restore Multifocal Lense - New Hope for Cataract Surgery PatientsJuly 13th, 2006 Has your vision lost the luster it once had or have you been diagnosed with a cataract? Are you having difficulty in seeing near? If you are over 45 years of age, there may be new hope. Dr. Khanna, medical director of the Khanna Institute of LASIK and Refractive Surgery (has offices in Westlake Village, Santa Monica and Valencia), is now offering a new treatment modality, the ReSTOR lens that relies on advanced multi-focal technology that allows patients to see both near and far objects without glasses.
Cytogenetic test of eye cancer - it helps correct diagnosisJune 18th, 2009 Has your doctor recommended cytogenetic test for your eyes after he has diagnosed a tumor in them? Are you unaware about what the study is and what it does? We hope that after reading through this, you will be helped. Take a brief explanation of the study in simple words made easy for you to understand.
Salmona, tuna 'protects against age-related macular degeneration'June 19th, 2009 WASHINGTON - Omega-3 fatty acids found in fatty fish such as tuna and salmon may help prevent age-related macular degeneration (AMD) progression, depending upon the stage of the disease, suggest researchers. AMD is a progressive disease that attacks central vision, resulting in a gradual loss of eyesight and, in some cases, blindness
During the study, the research team from Laboratory for Nutrition and Vision Research (LNVR) and Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University calculated the intakes of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) among 2,924 patients aged 55 to 80 years.
ssue contains a large study of outcomes of incisional surgeries, used to reduce the pressure inside the eye of the Medicare patients.
